Merck KGaA
์๊ฐ์ด์ก
$19.0B
๊ธ๋ก๋ฒ ์์
#331
์ญ๋ ์ต๊ณ ์น
$63.3B
2026-12-31
์ด ์ฑ์ฅ๋ฅ
+0%
2026๋ ์ดํ
Market Cap Context
- Larger than 10% of the 367 companies we track (globally).
- Equivalent to 0.4% of Germany's GDP (2025 data).
- Just above: #330 Unity Software Inc. ($20.0B)
- Just below: #332 Wipro Limited ($18.9B)
- Best year: 2021 (+63%). Worst year: 2002 (-37%).
Merck KGaA Financial Breakdown (FY 2025)
Source: Yahoo Finance โ MRK.DE annual filings (2025) (converted from EUR at 0.93) โ$22.7B revenue ยท $3.9B operating income ยท $2.8B net income
- โOperating margin: 17.3% on $22.7B in revenue.
- โR&D is 11.4% of revenue ($2.6B).
- โNet income margin: 12.4% โ $2.8B in profit.
- โFree cash flow: $2.1B (9.4% of revenue).
Cost / Operating Expenses
Total operating expenses $18.8B
Total
$17.9B
Capital Expenditures
$2.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$2.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Merck KGaA ์๊ฐ
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.
Merck KGaA ์๊ฐ์ด์ก ์ถ์ด (2026โ2026)
Merck KGaA vs Sector Peers by Market Cap
Merck KGaA ๋น๊ต
์์ ์ถ์ด
| ์ฐ๋ | ์๊ฐ์ด์ก | ์์ | ์ ๋ ๋๋น ๋ณํ |
|---|---|---|---|
| 2026 | $19.0B | #331(โ3) | +13.5% |
| 2025 | $16.8B | #334(โ8) | -10.7% |
| 2024 | $18.8B | #326 | -1.5% |
| 2023 | $19.1B | #326(โ28) | -19.2% |
| 2022 | $23.6B | #298(โ11) | -19.5% |
| 2021 | $29.3B | #287(โ29) | +63.3% |
| 2020 | $18.0B | #316(โ8) | +34.9% |
| 2019 | $13.3B | #308(โ15) | +18.6% |
| 2018 | $11.2B | #293(โ5) | +1.8% |
| 2017 | $11.0B | #288(โ29) | -8.5% |
| 2016 | $12.0B | #259(โ6) | +12.1% |
| 2015 | $10.7B | #253(โ7) | +15.3% |
| 2014 | $9.3B | #260(โ8) | +22.3% |
| 2013 | $7.6B | #268(โ12) | +32.4% |
| 2012 | $5.8B | #256(โ1) | +31.9% |
| 2011 | $4.4B | #255(โ13) | +31.3% |
| 2010 | $3.3B | #268(โ14) | -6.6% |
| 2009 | $3.6B | #254(โ27) | +3.3% |
| 2008 | $3.4B | #227(โ12) | -26.9% |
| 2007 | $4.7B | #239 | +15.4% |
| 2006 | $4.1B | #239(โ8) | +13.6% |
| 2005 | $3.6B | #231(โ1) | +40.7% |
| 2004 | $2.6B | #232(โ3) | +56.5% |
| 2003 | $1.6B | #235(โ5) | +36.0% |
| 2002 | $1.2B | #230(โ13) | -37.0% |
| 2001 | $1.9B | #217(โ22) | -9.8% |
| 2000 | $2.1B | #195(โ23) | +60.1% |
| 1999 | $1.3B | #172(โ23) | -22.5% |
| 1998 | $1.7B | #149 |
๊ธฐํ ํฌ์ค์ผ์ด ๊ธฐ์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
What is Merck KGaA's market cap?
Merck KGaA (MRK.DE) has a market capitalization of $19.0B, making it the #331 largest company in the world by market cap.
What was Merck KGaA's highest market cap?
Merck KGaA's all-time high market cap was $63.3B, reached in 2026-12-31. Its highest rank was #287 in 2021.
What sector is Merck KGaA in?
Merck KGaA is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry. It is based in Germany.
How has Merck KGaA's market cap changed over time?
Merck KGaA has been tracked since 2026. Its market cap has grown by 0% from $19.0B in 2026 to $19.0B today.